Jump to content

Obesity background

From Surgopaedia

Nomenclature

[edit | edit source]
  • Obesity:
    • BMI > 30
    • %BF >32% (women) or >25% (men)
    • Waist circumference >35 inches (women) or >40 inches (men)
    • Waist to hip ratio >0.85 (women) or >0.90 (men)
    • Abdominal/visceral obesity is much worse than 'gynoid obesity' which is fat in buttock region, more commonly seen in women
      • Central obesity causes metabolic syndrome whereas gynoid obesity is less likely to
  • Morbid obesity:
    • BMI >40

Epidemiology

[edit | edit source]

Pathophysiology

[edit | edit source]
  • In general, there is persistent hunger that is not satiated by the amounts of food that satisfy the non-obese
    • This leads to long-term positive energy balance, and accumulation of adipose tissue
    • Adipose tissue eventually develops reduced ability to assimilate excess calories
    • This leads to fat redistribution to other tissues, causing diverse health consequences
  • Metabolic actions of adipose tissue
    • Increased secretion of 'adipokines' - leptin, adiponectin, resistin and inflammatory cytokines - comes from white fat, as opposed to brown fat
    • Causes chronic low-grade inflammation, interfering with cellular processes, leading to metabolic derangements (T2DM, etc)
  • Ghrelin - the 'hunger hormone'
    • Levels decrease after meals
    • Acts on hypothalamus
    • Primarily produced in fundus of stomach
    • Regulates hunger together with leptin
  • Genetic
    • Specific genes - FTO, MC4R - however these only rarely are the sole cause of obesity, and generally become apparent in childhood.
    • Syndromes - Prader-Willi (deficits in ghrelin signalling)
  • Microbiome
    • May be a relationship between gut microbiome and obesity, suggested by some animal studies
  • Nutrition
    • Hypoalbuminaemia
    • Vitamin and micronutrient deficiencies are common
  • Weight regain
    • Body defends fat vigorously
    • Increased hunger, driven by ghrelin
    • Decreased energy expenditure, driven by multifactorial neurohormonal changes including reduced SNS input

Edmonton Obesity Scale

[edit | edit source]
  • Not necessarily directly correlated with BMI
  • Predicts mortality
    • Large BMI people may even be lower risk mortality than normal
  • Do not assume that larger BMI = harmful = need for treatment


Complications

[edit | edit source]
  • Cardiovascular
    • HTN
    • MI
    • Cardiomyopathy
    • DVT
    • Pulmonary HTN
    • Right heart failure
  • Pulmonary
    • OSA (35-94% amongst morbidly obese) - benefit from CPAP/BiPAP post-op to avoid hypoxia
    • Hypoventilation syndrome of obesity (Pickwickian syndrome)
      • Generally seen BMI >60
      • Plethoric face, maybe clinically cyanotic, with difficulty at mild exertion
      • High haematocrit and PaCO2 > PaO2
      • Elevated pulmonary artery pressure
    • Asthma
  • Metabolic
    • Metabolic syndrome
    • T2DM (see in 20-30% of bariatric surgery patients)
    • Hchol/hyperlipidaemia
  • GIT
    • GORD
    • Cholelithiasis
    • NASH cirrhosis - benefit from caloric restriction pre-op
  • MSK
    • Degenerative joint disease
    • Lumbar disc disease
    • Osteoarthritis
    • Ventral hernias
  • Genitourinary
    • Stress urinary incontinence
    • CKD (diabetes and HTN)
  • Gynaecologic
    • Menstrual irregularities
  • Skin/integumentary system
    • Fungal infections
    • Boils/abscesses
  • Oncologic
    • Cancer of thyroid, prostate, oesophagus, kidney, stomach, colon, rectum, GB, pancreas, breast, ovaries, cervix, and endometrium
  • Neurologic/psychiatric
  • Social